Health Condition 1: L650- Telogen effluvium
Conditions
Interventions
Intervention1: An oral multivitamin and multimineral supplement: Twice daily Oral
Control Intervention1: NIL: NIL
Sponsors
Abbott Healthcare Private Limited
Eligibility
Inclusion criteria
Inclusion criteria: Male and Female patients aged 18 to 60 years diagnosed with Telogen Effluvium by a dermatologist Willingness and ability to provide informed consent for participation in the study Agreement to comply with the prescribed Follihair AM PM and attend scheduled follow up assessments during the study period
Exclusion criteria
Exclusion criteria: Pregnancy or lactation, as hormonal changes during these periods can influence hair health Use of contraceptive medications with known hormonal effects that could affect hair growth Diagnosed with Androgenetic alopecia Concomitant use of drugs that cause hair loss as per dermatologist discretion Use of hair growth medications or treatments within the last 6 months, which may confound the study results as per treating dermatologist s discretion Use of nutritional supplements for hair loss in the last 3 months as per dermatologist s discretion Any known history of allergies or adverse reactions to the components of the study products- similar products as per dermatologist s discretion Current participation in other clinical trials involving hair health or dermatological treatments Any other medical conditions that could impact hair health as per dermatologist s discretion History of major surgical procedures or significant trauma in the last 6 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the effectiveness of the treatment with oral nutritional supplements in reducing hair loss at 12 weeks using hair pull testTimepoint: Baseline and 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate the effectiveness of treatment with oral nutritional supplements in reducing hair loss at 12 weeks using global assessment score the GAS a 7 point score from minus 3 severe worsening to plus 3 excellent improvement performed using standardized global photographs. To evaluate hair strength with hair pluck test at 12 weeks Satisfaction will be measured through patient satisfaction questionnaire and Physician satisfaction Questionnaire at 6 weeks and 12 weeks Assessment of the acceptability of the therapy by using a scale from 1 very accepted to 10 not accepted at 6 weeks and 12 weeks Assessment of patient compliance through pill counts and adherence to the prescribed regimen at 6 weeks & 12 weeksTimepoint: Baseline 6 weeks and 12 weeks | — |
Countries
India
Contacts
Public ContactDr Shivani Acharya
Abbott Healthcare Private Limited
Outcome results
None listed